In the second group of five basal BC cell lines (HCC1937, DU4475, MDAMB157, CAL120, and HCC1395), a primary, immediate oncogenic driver is the MEK/ERK pathway, with PKC and PI3K/AKT signaling playing a secondary role. This evidence concerns the gene AKT1 and breast cancer.